Roche Enter Obesity Market with Carmot Deal – European Pharmaceutical Manufacturer

Berkeley, California. Carmot’s R&D portfolio includes clinical stage subcutaneous and oral incretins with best-in-class potential to treat obesity …

Do you trust this headline?

Based on recent headline ratings, 67% of this readership currently trusts the local media, which has an average score of 85% regionally and is currently trending negative.

67%

Media Trust Score67%

In